These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2056 related articles for article (PubMed ID: 8219759)

  • 21. The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene.
    Galvin K; Krishna S; Ponchel F; Frohlich M; Cummings DE; Carlson R; Wands JR; Isselbacher KJ; Pillai S; Ozturk M
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8452-6. PubMed ID: 1326756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservation of calnexin in the early branching protozoan Tritrichomonas suis.
    Felleisen RS; Hemphill A; Ingold K; Gottstein B
    Mol Biochem Parasitol; 2000 Apr; 108(1):109-17. PubMed ID: 10802323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of melanosome-associated proteins by establishment of monoclonal antibodies and immunoscreening of a melanoma cDNA library through an anti-melanosome antibody.
    Dakour J; Jimbow K; Vinayagamoorthy T; Luo D; Chen H
    Melanoma Res; 1993 Oct; 3(5):331-6. PubMed ID: 8292889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calnexin: its molecular cloning and expression in the liver of the frog, Rana rugosa.
    Yamamoto S; Nakamura M
    FEBS Lett; 1996 May; 387(1):27-32. PubMed ID: 8654561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress relief protein modulation by calnexin.
    Vinayagamoorthy T; Rajakumar AR
    Ann N Y Acad Sci; 1996 Sep; 793():479-84. PubMed ID: 8906196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topological analysis of TMEM180, a newly identified membrane protein that is highly expressed in colorectal cancer cells.
    Anzai T; Matsumura Y
    Biochem Biophys Res Commun; 2019 Dec; 520(3):566-572. PubMed ID: 31615651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 expression in melanocytic lesions: a marker of malignant progression?
    Harwood CA; Green MA; Cook MG
    Br J Dermatol; 1996 Dec; 135(6):876-82. PubMed ID: 8977706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells.
    Hoerer M; Bogedain C; Scheer U; Heberger C; Steyrer S; Burger A; Maass G
    Int J Immunopharmacol; 1997; 19(9-10):473-9. PubMed ID: 9637341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
    Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
    Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemofiltration for locally advanced cancer].
    Gutman M; Sorkin P; Chaitchik S; Inbar M; Chen Z; Papo I; Klausner JM
    Harefuah; 1993 May; 124(9):534-8, 600. PubMed ID: 8340000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
    Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
    J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of superficial spreading melanoma in situ 2.5 mm in diameter.
    Ban M; Yoneda K; Yanagihara M; Mori S; Seko T
    J Dermatol; 1993 Jul; 20(7):432-5. PubMed ID: 8408926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
    Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
    Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of low-molecular-weight heparin and unfractionated heparin to prevent adhesion of human prostate and bladder carcinoma and melanoma cells to bovine endothelial monolayers. An in vitro study and review of the literature.
    Lersch C; Gericke D; Classen M
    Urol Int; 1996; 56(4):230-3. PubMed ID: 8776820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.
    Hom SS; Rosenberg SA; Topalian SL
    Cancer Immunol Immunother; 1993; 36(1):1-8. PubMed ID: 8422663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fair complexion and risk of malignant melanoma of the skin based on experience from the Danish Cancer Registry.
    Osterlind A
    Recent Results Cancer Res; 1993; 128():91-100. PubMed ID: 8356336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoselection of GRP94/endoplasmin from a KNRK cell-specific lambda gt11 library using antibodies directed against a putative heparanase amino-terminal peptide.
    De Vouge MW; Yamazaki A; Bennett SA; Chen JH; Shwed PS; Couture C; Birnboim HC
    Int J Cancer; 1994 Jan; 56(2):286-94. PubMed ID: 8314313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human early pregnancy factor/chaperonin 10 gene family.
    Summers KM; Murphy RM; Webb GC; Peters GB; Morton H; Cassady AI; Cavanagh AC
    Biochem Mol Med; 1996 Jun; 58(1):52-8. PubMed ID: 8809346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 103.